These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7141346)

  • 41. On the method of evaluating the development of an embryonic component in experimental teratology.
    Jelínek R; Dostál M
    Folia Morphol (Praha); 1972; 20(2):130-3. PubMed ID: 5021670
    [No Abstract]   [Full Text] [Related]  

  • 42. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.
    Azarbayjani F; Danielsson BR
    Teratology; 2001 Mar; 63(3):152-60. PubMed ID: 11283972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embryo transfer in the analysis of teratological responses of mice: a critical examination.
    Takano K; Biddle FG; Peterson AC; Miller JR
    Teratology; 1980 Jun; 21(3):333-8. PubMed ID: 7455922
    [No Abstract]   [Full Text] [Related]  

  • 44. Sagittal growth trends of the development of cleft palate in mice homozygous for the "paddle" gene.
    Johnston L; Nash DJ
    J Craniofac Genet Dev Biol; 1982; 2(4):265-76. PubMed ID: 7183705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tritiated cortisone distribution and induced cleft palate in mice.
    Nasjleti CE; Avery JK; Spencer HH; Walden JM
    J Oral Ther Pharmacol; 1967 Jul; 4(1):71-82. PubMed ID: 6053766
    [No Abstract]   [Full Text] [Related]  

  • 46. A glucocorticoid receptor in fetal mouse: its relationship to cleft palate formation.
    Hackney JF
    Teratology; 1980 Feb; 21(1):39-51. PubMed ID: 7385055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure.
    Miettinen PJ; Chin JR; Shum L; Slavkin HC; Shuler CF; Derynck R; Werb Z
    Nat Genet; 1999 May; 22(1):69-73. PubMed ID: 10319864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal changes associated with retinoic acid induced cleft palate in CD-1 mice.
    Degitz SJ; Francis BM; Foley GL
    J Craniofac Genet Dev Biol; 1998; 18(2):88-99. PubMed ID: 9672841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression of decorin and biglycan genes during palatogenesis in normal and retinoic acid-treated mice.
    Zhang Y; Mori T; Iseki K; Hagino S; Takaki H; Takeuchi M; Hikake T; Tase C; Murakawa M; Yokoya S; Wanaka A
    Dev Dyn; 2003 Apr; 226(4):618-26. PubMed ID: 12666199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of hydrocortisone acetate on the development of mouse embryo and foetus.
    Rogóyski A
    Probl Med Wieku Rozwoj; 1975; 4():227-32. PubMed ID: 1167969
    [No Abstract]   [Full Text] [Related]  

  • 51. Report of a new site-specific cleft palate teratogen.
    Pearn JH
    Nature; 1967 Aug; 215(5104):980-1. PubMed ID: 6069728
    [No Abstract]   [Full Text] [Related]  

  • 52. Critical periods for the teratogenicity of immune-suppressant Leflunomide in mice.
    Fukushima R; Kanamori S; Hirashiba M; Hishikawa A; Muranaka R; Kaneto M; Kitagawa H
    Congenit Anom (Kyoto); 2009 Mar; 49(1):20-6. PubMed ID: 19243413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of susceptibility to 6-aminonicotinamide and hydrocortisone-induced cleft palate.
    Erickson RP; Karolyi IJ; Diehl SR
    Life Sci; 2005 Mar; 76(18):2071-8. PubMed ID: 15826874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts.
    Erickson RP; Cao W; Acuña DK; Strnatka DW; Hunter RJ; Chau BT; Wakefield LV; Sim E; McQueen CA
    Mol Reprod Dev; 2008 Jun; 75(6):1071-6. PubMed ID: 18161794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of cleft palate in rats with intra-amniotic corticoids.
    Dostál M; Jelínek R
    Nature; 1971 Apr; 230(5294):464. PubMed ID: 4929979
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination therapy with folic acid and methionine in the prevention of retinoic acid-induced cleft palate in mice.
    Reynolds PR; Schaalje GB; Seegmiller RE
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):168-73. PubMed ID: 12797458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Significance of glycosaminoglycans content in developing mechanism of cleft palate].
    Fu Y; Li Z; Huang H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jan; 32(1):43-5. PubMed ID: 10677946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ENU (ethylnitrosourea) mutagenesis in cleft lip and/or palate pathogenesis in mice.
    Yamada T; Fujiwara K; Mishima K; Sugahara T
    Int J Oral Maxillofac Surg; 2005 Jan; 34(1):74-7. PubMed ID: 15617970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Backcross test demonstrates the linkage of glucocorticoid-induced cleft palate susceptibility to H-2.
    Bonner JJ; Tyan ML
    Teratology; 1982 Oct; 26(2):213-6. PubMed ID: 7157197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects on mouse gestation and embryo development of an injection of viper venom (Vipera aspis).
    Clavert J; Gabriel-Robez O
    Acta Anat (Basel); 1974; 88(1):11-21. PubMed ID: 4857721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.